Skip to main content
PMC home page
Gut logoLink to Gut
. 1985 Jun;26(6):639–641. doi: 10.1136/gut.26.6.639

Acute fulminant non-A, non-B hepatitis leading to chronic active hepatitis after treatment with cryoprecipitate.

C A Lee, P B Kernoff, P Karayiannis, H C Thomas
PMCID: PMC1432744  PMID: 3924749

Abstract

This report describes a carrier of haemophilia A who developed fulminant non-A, non-B hepatitis after transfusion with cryoprecipitate. She survived, but developed chronic active hepatitis.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter H. J., Holland P. V., Morrow A. G., Purcell R. H., Feinstone S. M., Moritsugu Y. Clinical and serological analysis of transfusion-associated hepatitis. Lancet. 1975 Nov 1;2(7940):838–841. doi: 10.1016/s0140-6736(75)90234-2. [DOI] [PubMed] [Google Scholar]
  2. Bamber M., Murray A. K., Weller I. V., Morelli A., Scheuer P. J., Thomas H. C., Sherlock S. Clinical and histological features of a group of patients with sporadic non-A, non-B hepatitis. J Clin Pathol. 1981 Oct;34(10):1175–1180. doi: 10.1136/jcp.34.10.1175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bamber M., Murray A., Arborgh B. A., Scheuer P. J., Kernoff P. B., Thomas H. C., Sherlock S. Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders. Gut. 1981 Oct;22(10):854–859. doi: 10.1136/gut.22.10.854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berman M., Alter H. J., Ishak K. G., Purcell R. H., Jones E. A. The chronic sequelae of non-A, non-B hepatitis. Ann Intern Med. 1979 Jul;91(1):1–6. doi: 10.7326/0003-4819-91-1-1. [DOI] [PubMed] [Google Scholar]
  5. Collins J. D., Bassendine M. F., Codd A. A., Collins A., Ferner R. E., James O. F. Prospective study of post-transfusion hepatitis after cardiac surgery in a British centre. Br Med J (Clin Res Ed) 1983 Nov 12;287(6403):1422–1424. doi: 10.1136/bmj.287.6403.1422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dienes H. P., Popper H., Arnold W., Lobeck H. Histologic observations in human hepatitis non-A, non-B. Hepatology. 1982 Sep-Oct;2(5):562–571. doi: 10.1002/hep.1840020509. [DOI] [PubMed] [Google Scholar]
  7. Gimson A. E., White Y. S., Eddleston A. L., Williams R. Clinical and prognostic differences in fulminant hepatitis type A, B and non-A non-B. Gut. 1983 Dec;24(12):1194–1198. doi: 10.1136/gut.24.12.1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Karvountzis G. G., Redeker A. G., Peters R. L. Long term follow-up studies of patients surviving fluminant viral hepatitis. Gastroenterology. 1974 Nov;67(5):870–877. [PubMed] [Google Scholar]
  9. Luo K. X., Karayiannis P., Burns D. M., Bamber M., Kernoff P., Thomas H. Prevalence of a non-A, non-B-associated antigen/antibody system detected by radioimmunoassay in acute and chronic liver disease. J Med Virol. 1983;12(4):253–265. doi: 10.1002/jmv.1890120405. [DOI] [PubMed] [Google Scholar]
  10. Mannucci P. M., Ruggeri Z. M., Pareti F. I., Capitanio A. 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases. Lancet. 1977 Apr 23;1(8017):869–872. doi: 10.1016/s0140-6736(77)91197-7. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES